An analysis on human medicines recommended by EMA from 2010 to 2014LI Xuan, DU Xiao-chun, ZONG Xin2770-2774
General consideration of non-clinical safety evaluation of traditional Chinese medicine for pediatric useHUANG Fang-hua, ZHU Fei-peng, DA Hong-yuan, HAN Ling2779-2781
Data quality in clinical pharmacokinetic trials of new drugs in ChinaYAN Bei, LI Ke-xin2782-2786,2792
Regulatory requirements related to the bioanalytical techniques and pharmacokinetic evaluation of nucleic acid drugsFU Jie, SONG Hai-feng2787-2792
Onco-driver genes and their signaling networks in non-small cell lung cancerAN Shi-min, DING Xu-ping, ZHU Liang2797-2802
Recent advances in research of AMPK activators as anticancer agentsJIANG Xiao-ding, HU Li-qing, YI Rui, LI Qian-bin2803-2813,2825